calcium laevo-aspartate

aspartic acid, calcium salt, L-

CAS: 21059-46-1 C4 H5 Ca N O4 MW: 171.16565000

All Ingredients Aromatic Ingredients CAS Numbers EINECS Numbers Food Additives - Direct M.W Index

Identification

Name	calcium laevo-aspartate
CAS Number	21059-46-1
EINECS	244-185-8
FDA UNII	T9680JD4IY
Molecular Formula	C4 H5 Ca N O4
Molecular Weight	171.16565000
MDL Number	MFCD00045869
Nikkaji Number	J62.327J

Regulatory

Physical Properties

Appearance	white crystalline hygroscopic powder (est)
Assay	98.00 to 100.00
Food Chemicals Codex Listed	No
Boiling Point	264.00 to 265.00 °C. @ 760.00 mm Hg (est)
Vapor Pressure	0.002890 mmHg @ 25.00 °C. (est)
Flash Point	236.00 °F. TCC ( 113.50 °C. ) (est)
logP (o/w)	-0.669 (est)
Soluble in	water

Cosmetic Information

CosIng	cosmetic data
Cosmetic Uses	skin conditioning

No sensory data available

Safety Information

Oral/Parenteral Toxicity	intraperitoneal-mouse LD50 1059 mg/kg
Dermal Toxicity	Not determined
Inhalation Toxicity	Not determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Category	nutrient supplements
Recommendation for calcium laevo-aspartate usage levels up to	not for fragrance use.
Recommendation for calcium laevo-aspartate flavor usage levels up to	not for flavor use.

BOC Sciences

Best of Chemicals Supplier

Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...

21059-46-1 calcium L-aspartate

View All Website 1-631-485-4226 account@bocsci.com

Potential Uses

None Found

Natural Occurrence

not found in nature

Synonyms

L- aspartate Calcium L- aspartic acid, calcium salt (1:1) aspartic acid, calcium salt, L- calcium (2S)-2-aminobutanedioate calcium (2S)-2-aminosuccinate calcium di-L-aspartate calcium di-laevo-aspartate calcium L-aspartate calcium-L-aspartate PubMed: Rapid improvement of osteomalacia by treatment in a case with SjÃ¶gren's syndrome, rheumatoid arthritis and renal tubular acidosis type 1. PubMed: Effect of calcium supplementation on the vascular sensitivity to angiotensin II in pregnant women.